DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution

Monday 5 January 2015

Production of 4-hydroxy-3-(1-phenyl-vinyl)-benzoic acid ethylester

EXAMPLE 7
Production of 4-hydroxy-3-(1-phenyl-vinyl)-benzoic acid ethylester

Preparation:
4.98 g (30 mmole) p-hydroxybenzoic acid ethylester
3.06 g (30 mmole) phenylacetylene
31.26 g (120 mmole) tin tetrachloride
22.24 g (120 mmole) tributylamine
150 ml 1,2-dichlorethane
Method:
Under an argon atmosphere, a solution of 4.98 g (30 mmole) phydroxy-benzoic acid ethylester, 3.06 g (30 mmole) phenylacetylene, 31.26 g (120 mmole) tin tetrachloride and 22.24 (120 mmole) tributylamine in 150 ml 1,2-dichlorethane are heated for 1 h with recycling. Then 60 ml 4 M KOH and 30 ml ethanol are added to the reaction mixture and heated for 1 h with recycling. Following cooling, the solution is acidified with 4 M HCl and extracted twice with 150 ml diethylether each time. The purified organic phases are dried through MgSO4 and the solvent is removed on the rotary evaporator. The remaining residue undergoes absorptive filtering (silica gel, MTBE) and the raw product obtained in this way is cleaned by column chromatography (silica gel, toluene/MTBE=8/1 (v/v)). 2.63 g (9.8 mmole, 33%) 4-hydroxy-3-(1-phenyl-vinyl)-benzoic acid-ethylester are obtained.
Yield: 2.63 g (9.8 mmole, 33%) 4-hydroxy-3-(1-phenyl-vinyl)-benzoic acid-ethylester.  

1H-NMR (400 MHz, CDCl3): δ [ppm]=1.36 (t, 3J=7.1 Hz, 3H, CH3), 4.33 (q, 3J=7.1 Hz, 2H, OCH2), 5.44 (d, 2J=0.9 Hz, 1H, ═CH2), 5.91 (d, 2J=0.9 Hz, 1H, ═CH2), 6.97 (d, 3J=8.5 Hz, 1H, PhH), 7.34 (m, 5H, PhH), 7.89 (d, 4J=2.1 Hz, 1H, PhH), 7.96 (dd, 3J=8.5 Hz, 4J=2.1 Hz, 1H, PhH).  

13C-NMR (100 MHz, CDCl3): δ [ppm]=14.3 (CH3), 60.8 (OCH2), 115.8 (CHarom), 117.5 (═CH2), 122.9 (Cqarom), 126.9 (2×CHarom) 127.5 (Cqarom), 128.8 (3×CHarom), 131.3 (CHarom), 132.3 (CHarom), 138.7 (Cqarom), 144.3 (Cqolefin), 157.1 (Cqarom), 166.3 (COOEt).

MS (EI, 70EV): m/z [%]=268 (M+, 98), 267 (100), 253 (35) 239 (32), 225 (13), 223 (24), 194 (6), 165 (20), 152 (12), 115 (5), 111 (6), 104 (7).


 http://www.google.com/patents/US6809225


 




 






DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com


No comments:

Post a Comment